Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarction

Am J Cardiol. 2004 Dec 15;94(12):1537-9. doi: 10.1016/j.amjcard.2004.08.033.

Abstract

Patients (n = 1,106) were chosen from the conservative arm of the Treat Angina with aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction (TACTICS-TIMI) 18 trial. Only 1 patient had a myocardial infarction and another died on the day of stress testing (mortality 0.12%). In patients with unstable angina pectoris or non-ST-elevation myocardial infarction treated with aspirin, heparin, and tirofiban, performance of an exercise or a pharmacologic stress test in selected patients within 48 to 72 hours after admission appears to be associated with a low risk of complications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angina, Unstable / diagnosis*
  • Aspirin / therapeutic use
  • Exercise Test* / adverse effects
  • Exercise Test* / methods
  • Female
  • Heparin / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnosis*
  • Myocardial Infarction / drug therapy
  • Safety
  • Tirofiban
  • Tyrosine / analogs & derivatives*
  • Tyrosine / therapeutic use

Substances

  • Tyrosine
  • Heparin
  • Tirofiban
  • Aspirin